2.00USD
378.58 MUSD
5.80 BUSD
117.23 M
About UCB S.A.
Sector
CEO
Jean-Christophe Tellier
Headquarters
Brussels
Website
Employees (FY)
9.08 K
Founded
1925
ISIN
BE0003739530
FIGI
BBG000BTD2G7
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
UCB.BR short term bullish potential to challenge ATHConclusion:
A substantial break above 100, preferably above 107 signals a short term bullish potential, challenging ATH and beyond.
A drop below 75 on the other hand renders long term bearish or at least choppy consolidation.
For short term play targeting 108 minimally, with tight stop just under 96
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of UCBJF is 128.50 USD — it has decreased by 0.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange UCB S.A. stocks are traded under the ticker UCBJF.
UCB S.A. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
UCBJF stock is 0.18% volatile and has beta coefficient of 1.02. Check out the list of the most volatile stocks — is UCB S.A. there?
UCBJF earnings for the last quarter are 2.87 USD per share, whereas the estimation was 1.84 USD resulting in a 55.93% surprise. The estimated earnings for the next quarter are 1.48 USD per share. See more details about UCB S.A. earnings.
UCB S.A. revenue for the last quarter amounts to 2.82 B USD despite the estimated figure of 2.77 B USD. In the next quarter revenue is expected to reach 2.81 B USD.
Yes, you can track UCB S.A. financials in yearly and quarterly reports right on TradingView.
UCBJF stock has risen by 1.94% compared to the previous week, the month change is a 9.33% rise, over the last year UCB S.A. has showed a 34.48% increase.
UCBJF net income for the last quarter is 35.32 M USD, while the quarter before that showed 339.22 M USD of net income which accounts for −89.59% change. Track more UCB S.A. financial stats to get the full picture.
Today UCB S.A. has the market capitalization of 24.72 B, it has increased by 2.54% over the last week.
Yes, UCBJF dividends are paid annually. The last dividend per share was 1.03 USD. As of today, Dividend Yield (TTM)% is 0.76%. Tracking UCB S.A. dividends might help you take more informed decisions.
UCB S.A. dividend yield was 1.21% in 2023, and payout ratio reached 52.65%. The year before the numbers were 1.27% and 42.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, UCBJF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB S.A. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 9.08 K employees. See our rating of the largest employees — is UCB S.A. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UCB S.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UCB S.A. stock shows the strong buy signal. See more of UCB S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on UCB S.A. future price: according to them, UCBJF price has a max estimate of 176.09 USD and a min estimate of 112.05 USD. Read a more detailed UCB S.A. forecast: see what analysts think of UCB S.A. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB S.A. EBITDA is 1.49 B USD, and current EBITDA margin is 18.47%. See more stats in UCB S.A. financial statements.